“…Interestingly, down-regulation of Lipocalin2 (LCN2), a marker for kidney injury (Viau et al, 2010), implicated in kidney epithelial cell morphogenesis (Gwira et al, 2005) and previously shown to be dysregulated in Apc Min/+ intestinal adenomas (Reichling et al, 2005), was observed in the APC shRNA MDCK cells. Other dysregulated genes including the alpha 1 subunit of type IV collagen (COL4A1, a basement membrane component), C-X-C chemokine receptor type 7 (CXCR7), and ADAM metallopeptidase with thrombospondin type 1, motif 6 (ADAMTS6), are implicated in controlling cell-cell or cell-matrix interactions (Kuhn, 1995; Bevitt et al, 2005; Hou et al, 2010; Aikio et al, 2012). These data collectively support a model in which APC loss-of-function in epithelial cells (through mutation and deletion of its c-terminus or gene silencing) leads to loss of polarity and tissue architecture, and subsequent tumor initiation, via altered communication between neighboring cells and the substratum.…”